Dr. Renato Lopes and Dr. C. Michael Gibson discuss the results of the PARCUTE-HF trial testing the benefits of 2 drugs in a big but neglected population, those patients with Chagas Disease and Heart Failure September 1, 2025 Uncategorized PARACHUTE_ESC_21aug2025_FINAL PRESS CONFERENCEDownload Disclosures: TBD Article Navigation Dr. Kevin Alexander and Dr. C. Michael Gibson discuss: Acoramidis reduces cardiovascular mortality (CVM): results at month 42 from the ATTRibute-CM open-label extension (OLE) study
